Establishment Labs Holdings (ESTA) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 68.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.27% |
| Dec 31, 2025 | 82.71% |
| Sep 30, 2025 | 73.76% |
| Jun 30, 2025 | -31.46% |
| Mar 31, 2025 | -43.58% |
| Dec 31, 2024 | 38.44% |
| Sep 30, 2024 | 56.75% |
| Jun 30, 2024 | 52.44% |
| Mar 31, 2024 | 7.18% |
| Dec 31, 2023 | 14.78% |
| Sep 30, 2023 | -110.97% |
| Jun 30, 2023 | -23.33% |
| Mar 31, 2023 | 10.68% |
| Dec 31, 2022 | -48.56% |
| Sep 30, 2022 | 31.28% |
| Jun 30, 2022 | -49.00% |
| Mar 31, 2022 | -154.73% |
| Dec 31, 2021 | -11.05% |
| Sep 30, 2021 | -339.32% |
| Jun 30, 2021 | 54.28% |
| Mar 31, 2021 | 73.40% |
| Dec 31, 2020 | -75.17% |
| Sep 30, 2020 | 81.51% |
| Jun 30, 2020 | -21.13% |
| Mar 31, 2020 | 4.03% |
| Dec 31, 2019 | 45.59% |
| Sep 30, 2019 | -77.02% |
| Jun 30, 2019 | -28.03% |
| Mar 31, 2019 | -182.03% |
| Dec 31, 2018 | -48.27% |
| Sep 30, 2018 | -207.40% |
| Jun 30, 2018 | 46.23% |